SEC Form 4 · accession 0001209191-16-093437
Tracon Pharmaceuticals, Inc. · TCON
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patricia L Bitar
Officer — CFO
Period of report
Jan 21, 2016
Accepted (ET)
Jan 25, 2016 · 4:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001394319
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jan 21, 2016 | A | 32,450 | $0.00 | A | 32,943 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2015 Equity Incentive Plan. The RSUs are scheduled to vest in four equal annual installments.
- F2Includes 493 shares acquired under the 2015 Equity Incentive Plan on October 20, 2015.